Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Polymeric Micellar Paclitaxel-Based Chemoimmunotherapy Plus Lenvatinib After First-Line Chemoimmunotherapy in Advanced Biliary Tract Cancer

NCT07159204 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.

NCT NCT07159204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07159204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Polymeric Micellar Paclitaxel-Based Chemoimmunotherapy Plus Lenvatinib After First-Line Chemoimmunotherapy in Advanced Biliary Tract Cancer
Lead sponsor
Peking Union Medical College Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 7, 2024
Completion date
December 7, 2027
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer (btc)